Eculizumab Modifies Outcomes in Adults with Atypical Hemolytic Uremic Syndrome with Acute Kidney Injury
Conclusion: Eculizumab shows greater efficacy than PE/PI alone for the treatment of adult aHUS patients with AKI. Prospective studies and meta-analyses are warranted to confirm our findings and set guidelines for treatment, monitoring, and maintenance.Am J Nephrol 2018;48:225 –233
Source: American Journal of Nephrology - Category: Neurology Source Type: research
More News: Dialysis | Genetics | Hematology | Hemolytic Uremic Syndrome (HUS) | Hypertension | Neurology | Proteinuria | Rare Diseases | Study | Urology & Nephrology